Bhutan vs Denmark: The number of people with susceptibility test result for rifampicin
Bhutan
96.77
in 2021
Denmark
96.58
in 2021
Bhutan rank
40th
Denmark rank
43rd
The number of people with susceptibility test result for rifampicin over time
- Bhutan
- Denmark
How they compare
Bhutan currently reports 96.77 against 96.58 in Denmark, a difference of 0.19.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Denmark ahead.
Bhutan ranks 40th and Denmark ranks 43rd of 146 countries.
Across the 2 decades both report, Bhutan averaged higher in 1 and Denmark in 1.
Head to head by decade
| Decade | Bhutan | Denmark | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 93.89 | 97.19 | 3.31 | Denmark |
| 2020s | 98.38 | 96.41 | 1.97 | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Bhutan or Denmark?
- Bhutan, at 96.77 against 96.58 in Denmark as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Bhutan and Denmark?
- 0.19, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Denmark?
- 5 years are reported by both, from 2017 to 2021.
- How do Bhutan and Denmark rank globally for the number of people with susceptibility test result for rifampicin?
- Bhutan ranks 40th and Denmark ranks 43rd of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.